Debu Tripathy Selected Research

Debu Tripathy Research Topics

Disease

133	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2002
94	Neoplasms (Cancer) 05/2024 - 05/2002
31	Neoplasm Metastasis (Metastasis) 01/2024 - 02/2002
30	Triple Negative Breast Neoplasms 04/2024 - 12/2015
13	Pain (Aches) 09/2023 - 02/2002
13	Pathologic Complete Response 01/2023 - 02/2017
10	Disease Progression 04/2024 - 03/2004
8	Fatigue 05/2024 - 05/2002
7	Inflammatory Breast Neoplasms 04/2024 - 08/2017
5	Neutropenia 03/2023 - 01/2018
5	Brain Neoplasms (Brain Tumor) 11/2022 - 07/2019
5	Carcinogenesis 10/2021 - 01/2005
5	Cancer Pain 04/2011 - 02/2002
4	Circulating Neoplastic Cells 01/2020 - 12/2015
3	Residual Neoplasm 01/2023 - 11/2017
2	Death (Near-Death Experience) 05/2024 - 03/2015
2	Alopecia (Baldness) 03/2023 - 05/2002
2	Heart Diseases (Heart Disease) 01/2023 - 02/2002
2	Heart Failure 01/2023 - 10/2012
2	Ductal Carcinoma 12/2022 - 01/2018
2	Lobular Carcinoma 12/2022 - 01/2018
2	Overweight 10/2021 - 01/2018
2	Hyperglycemia 10/2021 - 04/2014
2	Hypertension (High Blood Pressure) 05/2019 - 04/2014
2	Obesity 01/2019 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 04/2014
2	Mood Disorders (Mood Disorder) 01/2017 - 11/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2013 - 10/2012

Drug/Important Bio-Agent (IBA)

37	Hormones (Hormone)IBA 12/2023 - 02/2008
22	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2012
21	Trastuzumab (Herceptin)FDA Link 12/2023 - 02/2002
14	Estrogen ReceptorsIBA 01/2022 - 01/2011
10	ErbB Receptors (EGF Receptor)IBA 10/2023 - 02/2014
9	human ERBB2 proteinIBA 01/2021 - 07/2012
8	Proteins (Proteins, Gene)FDA Link 03/2023 - 01/2014
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2016
8	RNA (Ribonucleic Acid)IBA 05/2022 - 05/2002
8	Analgesics (Analgesic Drugs)IBA 06/2011 - 02/2002
7	palbociclibIBA 12/2023 - 01/2017
7	ribociclibIBA 03/2022 - 01/2017
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2018
5	Phosphotransferases (Kinase)IBA 01/2024 - 12/2015
5	Messenger RNA (mRNA)IBA 12/2023 - 01/2014
5	Cyclin-Dependent Kinase 4IBA 01/2022 - 01/2017
5	pertuzumabIBA 11/2021 - 01/2016
5	Capecitabine (Xeloda)FDA Link 10/2020 - 04/2007
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 08/2017
4	Circulating Tumor DNAIBA 12/2023 - 10/2017
4	AnthracyclinesIBA 09/2023 - 01/2016
4	Ado-Trastuzumab EmtansineIBA 11/2021 - 01/2016
4	Gemcitabine FDA Link 01/2021 - 05/2002
4	Progesterone Receptors (Progesterone Receptor)IBA 10/2020 - 12/2015
4	taxaneIBA 07/2019 - 02/2008
4	Lapatinib (GW572016)FDA Link 07/2019 - 01/2019
4	Letrozole (Femara)FDA LinkGeneric 07/2019 - 02/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2002
4	Estrogens (Estrogen)FDA Link 02/2014 - 01/2005
4	Ibandronic Acid (Boniva)FDA Link 04/2007 - 10/2004
3	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 11/2016
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2023 - 01/2017
3	130-nm albumin-bound paclitaxelIBA 06/2023 - 01/2018
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 11/2017
3	etirinotecan pegolIBA 11/2022 - 07/2019
3	neratinibIBA 06/2021 - 10/2017
3	thiamine triphosphorate (TTP)IBA 01/2021 - 10/2004
3	Epidermal Growth Factor (EGF)IBA 10/2020 - 12/2018
3	AgarIBA 06/2019 - 10/2006
2	N-acetyltalosaminuronic acid (NAT)IBA 03/2024 - 09/2015
2	Phenobarbital (Luminal)FDA Link 03/2024 - 01/2014
2	Monoclonal AntibodiesIBA 03/2023 - 03/2009
2	Immune Checkpoint InhibitorsIBA 12/2022 - 01/2018
2	LigandsIBA 11/2022 - 07/2017
2	EnzymesIBA 01/2022 - 05/2002
2	Proteoglycans (Proteoglycan)IBA 01/2021 - 02/2018
2	Aromatase InhibitorsIBA 01/2020 - 01/2005
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2017
2	Epithelial Cell Adhesion MoleculeIBA 01/2020 - 12/2015
2	Formaldehyde (Formol)FDA Link 12/2019 - 08/2018
2	ParaffinIBA 12/2019 - 08/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019 - 02/2014
2	Histone Deacetylase InhibitorsIBA 01/2019 - 08/2017
2	entinostat (MS 275)IBA 01/2019 - 08/2017
2	CateninsIBA 12/2018 - 02/2016
2	Bevacizumab (Avastin)FDA Link 09/2018 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2017 - 08/2017
2	AntibodiesIBA 01/2017 - 03/2009
2	Growth Factor ReceptorsIBA 02/2015 - 02/2014
2	Doxycycline (Periostat)FDA LinkGeneric 02/2012 - 01/2011

Therapy/Procedure

77	Therapeutics 04/2024 - 05/2002
32	Neoadjuvant Therapy 03/2024 - 01/2003
27	Drug Therapy (Chemotherapy) 04/2024 - 03/2004
6	Pain Management 06/2011 - 04/2002
4	Integrative Oncology 05/2024 - 01/2017
3	Aftercare (After-Treatment) 05/2024 - 01/2018
2	Biological Therapy 01/2021 - 09/2015
2	Radiotherapy 12/2020 - 10/2019
2	Music Therapy 01/2017 - 11/2014
2	Massage (Zone Therapy) 01/2017 - 11/2014
2	Meditation 01/2017 - 11/2014
2	Precision Medicine 08/2014 - 03/2009